Literature DB >> 7654392

Basic principles of MR contrast.

K L Nelson1, V M Runge.   

Abstract

The use of intravenous contrast media is well established in magnetic resonance (MR) for improved diagnosis. MR differs from other imaging modalities in the complexity of signal and contrast dependence, with the method of measurement having great impact on tissue contrast. Unlike computed tomography, in which contrast depends solely on x-ray density, the signal intensity on MR is determined by differences in spin density, T1 and T2 relaxation times, diffusion, perfusion, and magnetic susceptibility. The only contrast agents in widespread clinical use at this time are paramagnetic metal ion chelates. These compounds influence tissue contrast by enhancing T1 and T2 relaxation. The effectiveness of any one agent is dependent on a number of basic parameters, including concentration, number of coordination sites, magnetic moment, distance between the ion and water protons, and correlation times. An understanding of general contrast mechanisms, principles of contrast agent design, and basic MR imaging techniques is important for proper clinical implementation and medical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654392

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  12 in total

Review 1.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

2.  Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using a quantitative evaluation.

Authors:  Sebastian Niedermayer; Steven Sourbron; Maria Prompona; Clemens Cyran; Maximilian Reiser; Armin Huber
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-06       Impact factor: 2.357

Review 3.  Molecular imaging with nanoparticles: giant roles for dwarf actors.

Authors:  Paul Debbage; Werner Jaschke
Journal:  Histochem Cell Biol       Date:  2008-09-30       Impact factor: 4.304

4.  Micro-engineered local field control for high-sensitivity multispectral MRI.

Authors:  Gary Zabow; Stephen Dodd; John Moreland; Alan Koretsky
Journal:  Nature       Date:  2008-06-19       Impact factor: 49.962

Review 5.  Nanomedicine strategies for molecular targets with MRI and optical imaging.

Authors:  Dipanjan Pan; Shelton D Caruthers; Junjie Chen; Patrick M Winter; Angana SenPan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

6.  Effective performance of contrast enhanced SPACE imaging in clearly depicting the margin of pituitary adenoma.

Authors:  Yue Wu; Jing Wang; Zhenwei Yao; Zhong Yang; Zengyi Ma; Yongfei Wang
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

7.  Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy.

Authors:  Kannan M Krishnan
Journal:  IEEE Trans Magn       Date:  2010-07-01       Impact factor: 1.700

8.  Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.

Authors:  William S Bradham; Susan P Bell; Douglas W Adkisson; Holly M Smith; Frank E Harrell; Mark A Lawson; Henry Ooi; Douglas B Sawyer; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2016-12-08       Impact factor: 5.712

9.  The fabrication of uniform cylindrical nanoshells and their use as spectrally tunable MRI contrast agents.

Authors:  G Zabow; S J Dodd; J Moreland; A P Koretsky
Journal:  Nanotechnology       Date:  2009-08-28       Impact factor: 3.874

Review 10.  Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.

Authors:  Trung D Tran; Shelton D Caruthers; Michael Hughes; John N Marsh; Tillmann Cyrus; Patrick M Winter; Anne M Neubauer; Samuel A Wickline; Gregory M Lanza
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.